Aligos Therapeutics, Inc. (ALGS) — DEF 14A Filings
All DEF 14A filings from Aligos Therapeutics, Inc.. Browse 2 Proxy Statement reports with AI-powered summaries and risk analysis.
DEF 14A Filings (2)
-
Aligos Therapeutics Files 2025 Proxy Statement
— Apr 28, 2025 Risk: low
Aligos Therapeutics, Inc. filed its definitive proxy statement (DEF 14A) on April 28, 2025, for its annual meeting of stockholders. The filing covers the fiscal -
Aligos Therapeutics Announces 2024 Annual Meeting of Stockholders on June 27
— Apr 29, 2024 Risk: low
Aligos Therapeutics, Inc. (ALGS) filed a Proxy Statement (DEF 14A) with the SEC on April 29, 2024. Aligos Therapeutics, Inc. will hold its 2024 Annual Meeting o
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX